GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $467,157 | -91.0% | 9,409 | -89.2% | 0.01% | -91.9% |
| Q2 2023 | $5,207,607 | +775996.4% | 87,464 | +638.0% | 0.06% | +520.0% |
| Q1 2023 | $671 | -53.7% | 11,851 | -39.2% | 0.01% | -65.5% |
| Q4 2022 | $1,449 | -99.9% | 19,507 | -45.8% | 0.03% | -53.2% |
| Q1 2022 | $2,654,000 | +24.8% | 35,969 | +29.5% | 0.06% | +82.4% |
| Q3 2021 | $2,127,000 | +667.9% | 27,779 | +553.2% | 0.03% | +325.0% |
| Q4 2020 | $277,000 | -33.6% | 4,253 | -49.5% | 0.01% | -55.6% |
| Q3 2020 | $417,000 | -69.6% | 8,414 | -70.7% | 0.02% | -73.5% |
| Q2 2020 | $1,370,000 | +133.0% | 28,705 | +107.5% | 0.07% | +28.3% |
| Q1 2020 | $588,000 | -8.8% | 13,832 | +5.9% | 0.05% | +96.3% |
| Q1 2019 | $645,000 | -50.2% | 13,059 | -56.4% | 0.03% | +3.8% |
| Q4 2018 | $1,295,000 | +463.0% | 29,927 | +286.9% | 0.03% | +333.3% |
| Q3 2017 | $230,000 | -60.7% | 7,736 | -56.2% | 0.01% | -66.7% |
| Q2 2017 | $585,000 | +121.6% | 17,651 | +98.3% | 0.02% | +125.0% |
| Q1 2017 | $264,000 | -5.0% | 8,900 | -20.5% | 0.01% | +14.3% |
| Q4 2016 | $278,000 | -85.4% | 11,200 | -86.7% | 0.01% | -84.1% |
| Q3 2016 | $1,898,000 | -32.2% | 84,093 | -28.4% | 0.04% | -25.4% |
| Q2 2016 | $2,800,000 | +17.5% | 117,497 | +17.2% | 0.06% | -3.3% |
| Q1 2016 | $2,382,000 | +187.7% | 100,283 | +236.9% | 0.06% | +165.2% |
| Q4 2015 | $828,000 | -27.1% | 29,768 | -45.9% | 0.02% | -39.5% |
| Q3 2015 | $1,136,000 | +149.1% | 54,995 | +209.6% | 0.04% | +192.3% |
| Q2 2015 | $456,000 | -5.0% | 17,765 | -6.7% | 0.01% | -13.3% |
| Q1 2015 | $480,000 | -55.1% | 19,032 | -57.7% | 0.02% | -59.5% |
| Q4 2014 | $1,069,000 | +3.5% | 44,990 | -14.3% | 0.04% | 0.0% |
| Q3 2014 | $1,033,000 | +53.0% | 52,495 | +86.0% | 0.04% | +42.3% |
| Q2 2014 | $675,000 | +35.5% | 28,222 | +14.3% | 0.03% | +8.3% |
| Q4 2013 | $498,000 | +114.7% | 24,700 | +85.7% | 0.02% | +140.0% |
| Q3 2013 | $232,000 | +17.8% | 13,300 | +13.7% | 0.01% | -33.3% |
| Q2 2013 | $197,000 | – | 11,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |